NCT06538038 2026-03-27
Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients
PrECOG, LLC.
Recruiting
PrECOG, LLC.
Instituto Nacional de Cancerologia de Mexico
Oncology Center of Biochemical Education And Research
Fox Chase Cancer Center
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group